Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 574
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT04866810 The Effect of Diet and Exercise on ImmuNotherapy and the Microbiome (ED… |
The Effect of Diet and Exercise o… | Cancer | Non applicable | SUSPENDED | En attente / non publié | National Cancer Institute (NCI) | United States · Loma Linda University, Loma Linda, Un… | 2023-07-25 → 2028-10-31 | Ouvrir |
| NCT05081609 IL Believe — A Study to Investigate Safety and Tolerability of TransCon… |
TransCon IL-2 β/γ | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Ascendis Pharma Oncology Division… | United States, Australia, Belgium, Canada, Italy, Pol… | 2022-01-11 → 2029-08 | Ouvrir |
| NCT07061626 Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (… |
Rhenium-186 Nanoliposome | Cancer | Phase 1 | RECRUITING | En attente / non publié | Cerenome | United States · Ann & Robert H. Lurie Children's Hosp… | 2026-08-01 → 2028-03 | Ouvrir |
| NCT06487403 HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Electi… |
HN-BIO 02: A Phase II Randomized … | Cancer | Non applicable | RECRUITING | En attente / non publié | University Health Network, Toronto | Canada · Princess Margaret Cancer Centre, Toronto, Ca… | 2025-04-17 → 2028-08-01 | Ouvrir |
| NCT07103109 Impact of Proximal Motor Control Exercise on Scapular Muscles Activatio… |
Impact of Proximal Motor Control … | Cancer | Non applicable | COMPLETED | En attente / non publié | Ahram Canadian University | Egypt · Out patient clinic , faculty of Physical Ther… | 2025-08-05 → 2026-09-07 | Ouvrir |
| NCT03878550 Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection… |
Case-Control Study of the Glycote… | Cancer | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Glycotest, Inc. | United States, Israel · Baylor College of Medicine, H… | 2019-05-22 → 2027-12-31 | Ouvrir |
| NCT06303193 Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adul… |
pacritinib | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-09-16 → 2035-01-01 | Ouvrir |
| NCT05006716 CaDAnCe-101 — A Dose-Escalation and Expansion Study of Tacabrutideg (BG… |
Tacabrutideg | Cancer | Phase 1/2 | RECRUITING | En attente / non publié | BeOne Medicines | United States, Australia, Brazil, Canada, China, Fran… | 2021-09-13 → 2029-11 | Ouvrir |
| NCT05201248 A Study to Evaluate Adverse Events and Change in Disease Activity of Su… |
Epcoritamab | Cancer | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Genmab | China · Fujian Medical University Union Hospital /ID#… | 2022-03-10 → 2026-09 | Ouvrir |
| NCT07566156 Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Che… |
Enfortumab vedotin | Cancer | Phase 3 | RECRUITING | En attente / non publié | Astellas Pharma China, Inc. | United States, Canada · Compass Oncology - West, Tiga… | 2026-05-11 → 2032-02-29 | Ouvrir |
| NCT05630794 Testing for Safety and Colorectal Cancer Preventive Effects of ONC201 |
Biopsy Procedure | Cancer | Phase 1 | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · Cleveland Clinic Foundation, Clevelan… | 2025-10-06 → 2028-03-01 | Ouvrir |
| NCT05920356 A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembro… |
Sotorasib | Cancer | Phase 3 | RECRUITING | En attente / non publié | Amgen | United States, Argentina, Australia, Austria, Belgium… | 2023-11-16 → 2032-06-29 | Ouvrir |
| NCT06429761 STRIDE — Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, … |
Trastuzumab deruxtecan | Cancer | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | India · Research Site, Bangalore, India | Research Si… | 2025-01-02 → 2026-10-31 | Ouvrir |
| NCT07575685 Enhancing Cancer Care: RestoreMe App for Personalized Nutrition and Act… |
Enhancing Cancer Care: RestoreMe … | Cancer | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Montefiore Medical Center | Non communiqué | 2026-10 → 2035-10 | Ouvrir |
| NCT06393374 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC… |
Pembrolizumab | Cancer | Phase 3 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Austria, Belgium… | 2024-06-24 → 2037-12-14 | Ouvrir |
| NCT05206357 Study of the Adverse Events and Change in Disease State of Pediatric Pa… |
Epcoritamab | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Genmab | United States, Australia, Belgium, Canada, Czechia, F… | 2022-10-04 → 2028-11 | Ouvrir |
| NCT04969926 Natural History Study of Parathyroid Disorders |
Natural History Study of Parathyr… | Cancer | À vérifier | RECRUITING | En attente / non publié | National Institute of Diabetes an… | United States · National Institutes of Health Clinica… | 2021-11-30 → 2031-01-22 | Ouvrir |
| NCT06200155 Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on M… |
Psilocybin | Cancer | Phase 2 | RECRUITING | En attente / non publié | National Institute on Aging (NIA) | United States · MD Anderson Cancer Center, Houston, U… | 2024-04-16 → 2026-12-31 | Ouvrir |
| NCT07489378 NCI Childhood Cancer Data Initiative (CCDI) Led Pediatric, Adolescent, … |
NCI Childhood Cancer Data Initiat… | Cancer | À vérifier | RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-09-16 → 2037-04-01 | Ouvrir |
| NCT06291220 453 Ph1 CLL — A Study Assessing Adverse Event and How Oral ABBV-453 Mov… |
Obinutuzumab | Cancer | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States, Australia, Germany, Israel, Italy · At… | 2025-01-27 → 2027-07 | Ouvrir |
| NCT07714538 BRAVE — Breath Research Narrow Validation for Gastrointestinal Cancer D… |
BRAVE — Breath Research Narrow Va… | Cancer | À vérifier | RECRUITING | En attente / non publié | Imperial College London | United Kingdom · Imperial College Healthcare NHS Trus… | 2026-07-26 → 2028-08-02 | Ouvrir |
| NCT03799653 A Prospective Nurse Cohort Study in Xiamen, China |
A Prospective Nurse Cohort Study … | Hypertension | À vérifier | RECRUITING | En attente / non publié | The First Affiliated Hospital of … | China · The First Affiliated Hospital of Xiamen Unive… | 2019-03-20 → 2028-12-31 | Ouvrir |
| NCT04624204 Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pem… |
Pembrolizumab 200 mg | Parkinson | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | United States, Australia, Belgium, Bulgaria, Canada, … | 2020-12-08 → 2027-10-28 | Ouvrir |
| NCT04237337 PVSEPK — Drugs for the Treatment of Multiple Sclerosis and Risk of Canc… |
PVSEPK — Drugs for the Treatment … | SEP | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Caen | Non communiqué | 2020-01 → 2020-03 | Ouvrir |
| NCT06524570 iFOCUS — Treatment of Cancer With Immune Checkpoint Inhibition Therapy … |
Histotripsie — HistoSonics Edison… | Cancer | Phase 1 | RECRUITING | En attente / non publié | HistoSonics, Inc. | Netherlands · University Medical Center Utrecht, Utre… | 2024-07-26 → 2030-08-01 | Ouvrir |